A Novel Low Molecular Weight Inhibitor of Dendritic Cells and B Cells Blocks Allergic Inflammation

2006 ◽  
Vol 173 (6) ◽  
pp. 599-606 ◽  
Author(s):  
Peter Ettmayer ◽  
Peter Mayer ◽  
Frank Kalthoff ◽  
Wolfgang Neruda ◽  
Nathalie Harrer ◽  
...  
2011 ◽  
Vol 60 (10) ◽  
pp. 1383-1395 ◽  
Author(s):  
Laura Alaniz ◽  
Manglio Rizzo ◽  
Mariana G. Garcia ◽  
Flavia Piccioni ◽  
Jorge B. Aquino ◽  
...  

1989 ◽  
Vol 170 (5) ◽  
pp. 1477-1493 ◽  
Author(s):  
R H DeKruyff ◽  
T Turner ◽  
J S Abrams ◽  
M A Palladino ◽  
D T Umetsu

We have analyzed in detail the precise requirements for the induction of human IgE synthesis using several experimental approaches with purified B cells and well-characterized alloantigen-specific CD4+ T cell clones expressing different profiles of lymphokine secretion. Using these clones under cognate conditions in which the B cells expressed alloantigens recognized by the cloned T cells, we have confirmed that IL-4 is required for the induction of IgE synthesis, but we have clearly demonstrated that IL-4 by itself is not sufficient. With several cloned CD4+ T cell lines, including an IL-4-producing clone that could not induce IgE synthesis, and cloned T cells pretreated with cyclosporin A to inhibit lymphokine synthesis, we showed that Th cell-B cell interactions are necessary for IgE synthesis, and that low molecular weight B cell growth factor (LMW-BCGF) and IL-4, in combination, are lymphokines of major importance in the induction of IgE synthesis. Together our results indicate that optimal induction of an IgE-specific response requires the exposure of B cells to a particular complex of signals that include (a) a signal(s) involving Th-B cell interaction that primes B cells to receive additional signals from soluble lymphokines, (b) a specific B cell proliferative signal provided by LMW-BCGF, and (c) a specific B cell differentiation signal provided by IL-4.


1996 ◽  
Vol 33 (17-18) ◽  
pp. 1377-1388 ◽  
Author(s):  
Johannes W. Reim ◽  
David E. Symer ◽  
Douglas C. Watson ◽  
Renee Z. Dintzis ◽  
Howard M. Dintzis

2020 ◽  
Author(s):  
Marta Bermejo-Jambrina ◽  
Julia Eder ◽  
Tanja M. Kaptein ◽  
Leanne C. Helgers ◽  
Philip J.M. Brouwer ◽  
...  

AbstractThe current pandemic caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and new outbreaks worldwide highlight the need for preventive treatments. Although angiotensin converting enzyme 2 (ACE2) is the primary receptor for SARS-CoV-2, we identified heparan sulfate proteoglycans expressed by epithelial cells, alveolar macrophages and dendritic cells as co-receptors for SARS-CoV-2. Low molecular weight heparins (LMWH) blocked SARS-CoV-2 infection of epithelial cells and alveolar macrophages, and virus dissemination by dendritic cells. Notably, potent neutralizing antibodies from COVID-19 patients interfered with SARS-CoV-2 binding to heparan sulfate proteoglycans, underscoring the importance of heparan sulfate proteoglycans as receptors and uncover that SARS-CoV-2 binding to heparan sulfates is an important mechanism for neutralization. These results have imperative implications for our understanding of SARS-CoV-2 host cell entry and reveal an important target for novel prophylactic intervention.


2016 ◽  
Vol 75 (Suppl 2) ◽  
pp. 912.2-912
Author(s):  
K. Yoshimoto ◽  
K. Suzuki ◽  
E. Ishioka ◽  
A. Nishikawa ◽  
K. Sugahara ◽  
...  

2000 ◽  
Vol 82 (4) ◽  
pp. 326-330 ◽  
Author(s):  
Qing Li Wang ◽  
Xue Yuan Shang ◽  
Shi Ling Zhang ◽  
Jian Bo Ji ◽  
Yan Na Cheng ◽  
...  

Hyaluronan ◽  
2002 ◽  
pp. 457-468
Author(s):  
Christian C. Termeer ◽  
Peter Prehm ◽  
Jan C. Simon

2017 ◽  
Vol 44 ◽  
pp. 183-190 ◽  
Author(s):  
Ming Zhong ◽  
Cheng Zhong ◽  
Tingting Wang ◽  
Pei Hu ◽  
Guanghui Wang ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document